|
Volumn 123, Issue 6, 2012, Pages 901-903
|
Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin Gene (PARK2)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA SYNUCLEIN;
LEVODOPA;
PARK2 PROTEIN;
PROTEIN;
UNCLASSIFIED DRUG;
ADULT;
BRAIN PERFUSION;
CASE REPORT;
CLINICAL FEATURE;
EXON;
GENE DELETION;
GENE MUTATION;
HETEROZYGOSITY;
HUMAN;
LETTER;
LEWY BODY;
MALE;
NEUROIMAGING;
NEUROPATHOLOGY;
NEUROPSYCHOLOGICAL TEST;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PARKINSON DISEASE;
POINT MUTATION;
PRIORITY JOURNAL;
RIGIDITY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SUBSTANTIA NIGRA;
TREATMENT RESPONSE;
ADULT;
AGED;
AGED, 80 AND OVER;
HETEROZYGOTE;
HUMANS;
LEWY BODIES;
MALE;
MIDDLE AGED;
MUTATION;
PARKINSON DISEASE;
PEDIGREE;
UBIQUITIN-PROTEIN LIGASES;
|
EID: 84866359459
PISSN: 00016322
EISSN: 14320533
Source Type: Journal
DOI: 10.1007/s00401-012-0991-7 Document Type: Letter |
Times cited : (22)
|
References (6)
|